The DEA needs to lift the 100 patient limit on bupenorpine.
I don't know why this drug is regulated this way.
Bupenorpine is here. We have a problem with opioid addiction. Doctors should be able to prescribe the drug without going to a class, and then limit the number of patients who can take it.
The drug is expensive. Even the generic version is expensive?
I'm not a conspiracy theorist, but something is not right with the way this drug is regulated, and manipulated?
Some of my details are fuzzy, but the original manufacturer
of this drug fought hard to extend the patent.
When that failed, they scared Physicians into thinking your patients will abuse the drug if you don't use our expensive strips.
Antidotal, but I can honestly state it's a hard drug to abuse. It's not a fun drug. It is addictive though. This bit about having a low affinity for addiction might be true for some individuals. The people I know on it have a hard time getting off the drug.
I think people would be surprised to find out just how many people are on this drug; they shouldn't be nickeled and dimed by the cost of the drug, and endless expensive office visits.
(The average patient has usually suffered in life. Why give them a addictive drug and let doctors use the 100 patient limit as a excuse/incentive to raise the cost of mandatory office visits? The office visit is essentially--ok--you showed up and payed me--I will refill your addictive medication.)